Cheat Sheet: What is a 'PDS' — the most extreme fire weather warning that's issued again for this week By Fiona Ng Updated Feb 19, 2025 9:36 AM Published Jan 13, 2025 3:29 PM ...

Interim data being presented at ASCO 2023 Annual Meeting Demonstrated median progression-free survival (PFS) of 10.4 months Demonstrated 12-month overall survival (OS) rate of 87.1%A disease ...

PDS Biotechnology reports positive results in the phase 2 study of PDS0101 with Keytruda for head and neck cancer and plans for the phase 3 study. Find out why PDSB stock is a Buy.

Basel, Switzerland (PRWEB) October 22, 2007-- Almost one hundred PathData, ToxData and ReproData System users from all over the world attended the recent PDS Users Group Meeting held in Basel ...

Shares of PDS Biotechnology Corporation PDSB were up 23.8% on Dec 28 after management announced interim data from a phase II study, which evaluated a PDS0101-based triple combination therapy in ...

Instead of credible data, PDS Biotech delivers ‘results might get better, later’ promises By Adam Feuerstein Reprints Molly Ferguson/STAT ...